BORA PHARMACEUTICALS LTD (6472) — Working Capital to Net Assets Ratio
BORA PHARMACEUTICALS LTD (6472) has a Working Capital to Net Assets ratio of 32.9% as of March 2026. Working capital of NT$5.47 Billion (current assets of NT$19.81 Billion minus current liabilities of NT$14.34 Billion) is measured against net assets of NT$16.63 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of BORA PHARMACEUTICALS LTD to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BORA PHARMACEUTICALS LTD Working Capital to Net Assets (2019–2025)
This chart shows how BORA PHARMACEUTICALS LTD's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 32.9%, reflecting working capital of NT$5.47 Billion against net assets of NT$16.63 Billion TWD. See BORA PHARMACEUTICALS LTD liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for BORA PHARMACEUTICALS LTD (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for BORA PHARMACEUTICALS LTD from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 6472 company net worth.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 34.4% | NT$6.02 Billion | NT$17.47 Billion | NT$19.34 Billion | NT$13.32 Billion | ▼ -30.6 pp |
| 2024 | 65.0% | NT$9.76 Billion | NT$15.01 Billion | NT$23.57 Billion | NT$13.81 Billion | ▲ +44.8 pp |
| 2023 | 20.2% | NT$2.38 Billion | NT$11.77 Billion | NT$10.60 Billion | NT$8.23 Billion | ▼ -13.8 pp |
| 2022 | 34.0% | NT$1.75 Billion | NT$5.14 Billion | NT$12.24 Billion | NT$10.50 Billion | ▲ +3.8 pp |
| 2021 | 30.2% | NT$951.22 Million | NT$3.15 Billion | NT$2.79 Billion | NT$1.84 Billion | ▲ +16.4 pp |
| 2020 | 13.8% | NT$340.48 Million | NT$2.46 Billion | NT$2.63 Billion | NT$2.29 Billion | ▼ -27.9 pp |
| 2019 | 41.7% | NT$689.21 Million | NT$1.65 Billion | NT$1.25 Billion | NT$557.05 Million | — |